Is Belite Bio, Inc overvalued?

Belite Bio, Inc (BLTE) — key valuation metrics and fundamentals.

No verdict

Price

$166.28

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$6.67B

Dividend yield

0.0%

Return on equity

-18.1%

Sector

Healthcare

Fair value compares BLTE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks